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Abstract
Background: The collection of accurate data on adherence and sexual behaviour is crucial in microbicide (and other HIV-
related) research. In the absence of a ‘‘gold standard’’ the collection of such data relies largely on participant self-reporting.
After reviewing available methods, this paper describes a mixed method/triangulation model for generating more accurate
data on adherence and sexual behaviour in a multi-centre vaginal microbicide clinical trial. In a companion paper some of
the results from this model are presented [1].
Methodology/Principal Findings: Data were collected from a random subsample of 725 women (7.7% of the trial
population) using structured interviews, coital diaries, in-depth interviews, counting returned gel applicators, focus group
discussions, and ethnography. The core of the model was a customised, semi-structured in-depth interview. There were two
levels of triangulation: first, discrepancies between data from the questionnaires, diaries, in-depth interviews and applicator
returns were identified, discussed with participants and, to a large extent, resolved; second, results from individual
participants were related to more general data emerging from the focus group discussions and ethnography. A democratic
and equitable collaboration between clinical trialists and qualitative social scientists facilitated the success of the model, as
did the preparatory studies preceding the trial. The process revealed some of the underlying assumptions and routinised
practices in ‘‘clinical trial culture’’ that are potentially detrimental to the collection of accurate data, as well as some of the
shortcomings of large qualitative studies, and pointed to some potential solutions.
Conclusions/Significance: The integration of qualitative social science and the use of mixed methods and triangulation in
clinical trials are feasible, and can reveal (and resolve) inaccuracies in data on adherence and sensitive behaviours, as well as
illuminating aspects of ‘‘trial culture’’ that may also affect data accuracy.
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Introduction
The accurate measurement of product use and related
behaviour in microbicide trials (but also in many other fields) is
important for a number of reasons.
First, poor adherence reduces the chance of demonstrating
effectiveness. If a trial shows overall benefit then relating the level
of protection to adherence is valuable in interpreting the results,
and has important implications for predicting effectiveness in
real-life settings. Also, in order to properly interpret the results of
trials that do not show a protective effect, it is necessary to be able
to identify to what extent this may be due to the product not
being efficacious, participants not using it, or not using it
correctly, participants increasing protective behaviours such as
condom use, increased risky behaviour related to perceived
protection of the product, or other high-risk behaviours such as
anal sex [2,3].
Second, the use of investigational microbicides may negatively
affect participants, either directly as a result of harmful side effects
or indirectly as a result of changes in behaviour. Having accurate
data on product use and related behaviour is important for
assessing safety [2,3].
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Third, understanding the reasons for different levels of
adherence provides insights that are useful for the design of future
clinical trials and for facilitating rollout and access if the product
proves effective.
Finally, understanding the reasons for non-adherence and for
not reporting or inaccurately reporting non-adherence and other
relevant behaviours is also important because it can be fed back
into the trial and used to improve adherence and the accuracy of
adherence data. Similarly, understanding the issues involved in the
inaccurate reporting of sexual behaviour and other relevant
practices during the trial makes it possible to adjust data collection
techniques and improve accuracy.
The assumption among biomedical researchers is that the best
and most accurate measure of adherence (and other relevant
behaviours) would be a validated biomarker – some objective
biological indicator of whether the study product has been used or
whether the participant has engaged in certain behaviours (such as
condom use or unprotected sex). This could then be used as the
‘‘gold standard’’ against which the accuracy of other perhaps
easier and cheaper methods could be measured. Unfortunately,
although there are a number of potential biomarkers for both
sexual behaviour and vaginal microbicide use, these have either
not been adequately validated or are not feasible in large clinical
trials due to issues such as cost, logistics and acceptability. So in the
absence of a ‘‘gold standard’’, the collection of data on adherence,
sexual behaviour (including high-risk behaviours that are often
stigmatised) and vaginal practices relevant to microbicide studies,
relies largely on participant self-reporting, usually through
structured questionnaires.
The limitations of structured questionnaires for collecting sexual
behaviour and other sensitive data are well recognised. Also,
because of the sensitivity of the topics and the likelihood of
desirability bias, structured face-to-face interviews in a clinic
setting are not ideal for collecting accurate data (if project staff
promote condoms and ask participants to use gel every time they
have sex, then participants are more likely to report that they have
complied, and they are less likely to report stigmatised behaviours
such as anal sex). They are also not ideal for understanding
participants’ reasons for non-adherence or the scope and reasons
for inaccurate reporting. Various other methods, are available for
collecting self-reported sexual behaviour data, but these methods
also all have disadvantages. In recent years behavioural research
relating to HIV has moved increasingly toward using and
comparing different methods, and microbicide researchers have
started to experiment with methods based on participant self-
assessment techniques such as computer assisted self-interview
(CASI). Usually these studies report on the fit between data from
different self-report methods, or between self-report and biological
data.
The use of mixed methods in a single study has often revealed
inconsistencies between the data collected using different instru-
ments, but not much attempt has been made to find out why results
are inconsistent. The assumption seems to be that study
participants are simply unreliable when it comes to reporting this
kind of behaviour. There has also been no attempt to resolve the
inconsistencies that emerge during the study: different methods are
used, and the inconsistent results are only identified and discussed
after the completion of the study.
What is required is to move beyond mere comparison to
investigate and understand the reasons for divergent results, and
then attempt to increase the accuracy of the results. This can be
accomplished through the use of mixed methods and the
triangulation of results, in dialogue with participants, and during
the study. This paper reports on what is, as far as we are aware,
the largest and most comprehensive use of mixed methods and
triangulation in the context of medical research. It has generated a
rich and unique set of data on adherence and sexual and other
relevant behaviour.
In what follows we first review the pros and cons of the main
methods currently available (or being developed) for measuring
adherence and related behaviour in vaginal microbicide and
similar studies. Then, after briefly describing the Microbicides
Development Programme MDP301 Phase III trial, we describe in
detail the mixed method/triangulation model that has been
developed by the MDP team in an attempt to gather more
accurate data on adherence and sexual behaviour. In a separate
paper we discuss some of the findings from this process [1].
Overview of Available Methods for Measuring
Adherence and Sexual Behaviour
Respondent-independent methods
Because all self-reporting is ultimately dependent on the
truthfulness, memory and accuracy of the study participants, the
development and use of respondent-independent methods is seen
as a priority.
N Biomarkers. A biomarker has been defined as ‘‘a charac-
teristic that is objectively measured and evaluated as an
indicator of normal biological processes, pathogenic processes,
pharmacological responses to a therapeutic intervention’’ [4].
In microbicide research the main focus is on biomarkers of
semen exposure, cervicovaginal inflammation, HIV and STIs
[5]. The interest is in both surrogate endpoints and the
verification of behaviour. There are various candidate
biomarkers for semen exposure [6] and if validated these
could provide reliable evidence of unprotected intercourse.
However, they would not provide information on other
relevant behaviours (such as anal sex) or the reasons for
behaviours, or generate much information on adherence
(which would require a different biomarker). Pregnancy or
HIV or STI infection are sometimes used as biomarkers of
unprotected sex, but all they really tell us is that the participant
had at least one unprotected sex act (and in the case of HIV
infection there are other possible means of transmission).
N Applicator stain test. In the Carraguard vaginal gel efficacy
trial, product adherence was assessed through self-reports,
counting returned applicators and a staining test that was
meant to show which applicators had been vaginally inserted
[7,8,9]. However, the high proportion of empty applicators
that were not confirmed by the stain test (39%) suggests that
this technique may not have been adequately validated [10].
While potentially more reliable than self-reports, this method is
time consuming, open to observer bias (the staining has to be
interpreted), and is only proof that the applicator was inserted
into a vagina, not that it has been used by the participant in
question, or that the product was actually administered.
N ‘‘Smart applicators’’. The International Partnership for
Microbicides (IPM) is currently developing ‘‘smart applicators’’
that could register time, date and temperature when used, thus
providing some verification of product use. However, such
applicators would still miss essential information: they would
be unable to tell us whose vagina they have been in, whether
the participant had sex, what kind of partner she had, or the
reasons for non-adherence.
N Applicator returns. Counting used product applicators is a
relatively simple (though perhaps not really respondent-
independent) method for assessing product use in microbicide
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trials, and investigators consider this a relatively reliable
measure of adherence. However, it may be inconvenient for
participants or they may be unwilling to return applicators,
and it does not reveal whether the product was used as
intended (for example the gel might have been squeezed out in
order to return empty applicators, or it may have been used by
someone else). Also, in order to estimate adherence to products
that have to be inserted prior to sex, product counts still need
to be related to self-reported sex acts and timing of use. This
latter point also applies to the stain test and the smart
applicator.
All respondent independent methods, but particularly biomark-
ers and smart applicators, also raise serious questions about trust
and acceptability: how willing will study participants be to use
products that have been designed on the assumption that they (the
participants) are unreliable?
Self-report methods
Face-to-face interviews.
N Structured interviews, using pre-coded questionnaires or
case record forms (CRF), have been the main instrument for
collecting behavioural data in microbicide trials (and other
medical research). They efficiently generate large standardised
datasets that are relatively easy to manage and analyse. They
are, however, inflexible and prone to desirability bias. Also,
any systematic misunderstandings that occur during the
interviews are hidden in the neat dataset that results.
N Open or semi-structured in-depth interviews are more
flexible and enable detailed probing; they help to establish
closer rapport with interviewees, thus potentially facilitating
access to more sensitive topics. However, they are also open to
desirability bias and are only feasible with a sub-sample of
large trial populations. They are time-consuming, especially to
transcribe and translate, and difficult to analyse in a systematic
way because there are no universally accepted criteria for the
interpretation of results. They also require highly skilled
interviewers, who are often scarce.
Self-assessment. It is often argued that self-assessment
reduces the risk of desirability bias and therefore generates more
accurate reporting of sensitive behaviours. Various methods have
been, or are being, tried:
N Diaries are usually simple paper documents that participants
take home and fill in each time they have sex or use the study
product [11]. Because participants keep them at home, diaries
can reduce recall bias. However, participants may forget to fill
them in, and there is no way of knowing whether they were
completed as intended or all at once, just before handing them
in. They can also be misplaced or lost and there is no
immediate way for participants to seek clarification if
something is unclear. Diaries may also be prone to desirability
bias because participants know that researchers will be able to
link the data to them individually.
N CASI (computer assisted self-interviewing). Partici-
pants are given a computer or a hand-held electronic device
and asked to respond to visual cues on the screen or questions
that they hear through headphones [12,13]. CASI is becoming
increasingly popular because it is assumed to reduce
desirability bias. This assumption is based on higher reporting
of sensitive behaviours in CASI compared to face-to-face
interviews [14]. However, while this seems intuitively plausi-
ble, there is no clear evidence to support this, and there may be
other reasons for the higher reporting.
N Ballot boxes (or secret voting). Participants are asked to fill in
answers on a form that they then deposit anonymously in a
box [15]. This has not been widely used, but it is a simple and
cheap method and it seems plausible that participants might be
inclined to report more honestly on sensitive topics.
N Electronic and telephone messaging. This includes
participants using mobile phones, emails or the internet to
report behaviour (for example in the Adolescent Trials
Network microbicide study ATN-062 (running parallel to the
MTN-004 trial) participants will use a computerised phone
diary to describe their experiences with the study product
[16]). As yet there is no evidence on how such techniques work
in practice, but they have the potential of reducing recall bias,
though they may also be prone to desirability bias.
Despite their individual merits for measuring adherence and
sensitive behaviour, none of these self-assessment techniques are
capable of generating in-depth understanding of behaviours or
reasons for behaviours.
Other methods
There are a number of other methods that are used (or could be
used) in microbicide and related research to collect behavioural
information.
N Focus group discussions (FGD) are relatively easy and
cheap and have proved popular in collecting qualitative data
on acceptability. They can also be used to collect indirect
evidence on adherence and sexual behaviour, and they can be
a source of respondent-independent data (people reporting
other people’s behaviour) and of indirect self-report data
(respondents talking about themselves in the guise of talking
about what ‘‘others’’ do). They are also a rich source of
information on community norms and values. The main
disadvantage, especially relating to data on adherence and
sensitive behaviours, is that they are difficult to verify, may be
dominated by a small number of more vocal individuals, and
may not give any useful information on the frequency of
behaviours or attitudes. They also generate information that
tends toward the social norm.
N Ethnography. While not an obvious method for collecting
information on adherence or sensitive behaviour, and not
generally used in microbicide research, ethnography (including
informal observation and conversation) can be a rich source of
both direct and indirect data.
Mixed methods
One way of overcoming the disadvantages of individual
methods and enhancing the accuracy (and depth) of self-report
data is through the combination of different methods. There is a
growing methodological literature on mixed method research
[17,18,19,20], and even a dedicated Journal of Mixed Methods
Research. Although there is no precise and universally accepted
definition of ‘‘mixed methods’’ the term usually refers to some
combination of quantitative and qualitative methods. Mixed
methods are used for a variety of reasons:
1. To develop or evaluate study tools and procedures.
2. To examine different aspects of the research question.
3. To broaden the scope of the research.
4. To triangulate results in order to get more accurate data.
Methods in Microbicides Trials
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Qualitative methods are not commonly used in the context of
clinical trials, but when they are this is generally in the form of
small ancillary components aimed at collecting data on accept-
ability. They are also used to inform protocol development and
questionnaire design in the early stages of the trial [21], follow up
patients’ experiences after the trial [22], or for both preparatory
and evaluation purposes [23]. Qualitative methods are sometimes
used during trials to evaluate trial processes such as informed
consent, accrual and retention, usually resulting in suggestions for
improvement in future studies [24,25,26], or, occasionally, to
create a feedback loop between participants and researchers in
order to improve processes during the trial [27,28]. Recently there
have been calls to give qualitative methods a more central role in
clinical trials [29,30,31].
We do not limit the definition of ‘‘mixed methods’’ to the
combination of quantitative and qualitative approaches and we
consider that the use of different quantitative methods together, or
different qualitative methods, could also be described as ‘‘mixed
method’’ if they are used in the same project to study the same
phenomenon or different aspects of the same phenomenon. We
shall also avoid any theoretical discussion about the distinction
between ‘‘methods’’ and ‘‘techniques’’, mixed ‘‘methods’’ vs mixed
‘‘models’’, and what exactly the term ‘‘mixed methods’’ does or
should refer to.
Following this broader definition, there are various examples of
the use of mixed methods to collect behavioural data in medical
research on sexual and reproductive health. These studies have
been concerned with the accuracy of data on sensitive behaviours
and have often used biomarkers to validate self-report data. They
have had mixed results. For example, one study of men and
women attending an STI clinic in the US found that self-reported
condom use was not supported by STI incidence [32], while
another study, also of STI clinic attendees in the US, found that
self-reporting was supported by STI incidence data [33]. In
Zambia a study found that couples under-reported unprotected
sex when compared to STI incidence and a biomarker (presence of
semen) [34], and a study in Tanzania found that self-reports were
inconsistent compared to biomarkers, but that in-depth interviews
were better than self-completion questionnaires [35].
In microbicide research there is a trend towards experimenting
with new methods – particularly CASI – in combination with
more conventional ones, such as face-to-face interviews. CASI has
been used in three MTN clinical trials in an attempt to get more
accurate information on sexual behaviour. In the VOICE trial
(MTN-003), a Phase IIb study of Tenofovir vaginal gel and
Truvada tablets for the prevention of HIV infection in women,
CASI is being used to ask the questions the researchers deem
sensitive; at three of the South African Carraguard phase III trial
sites CASI was assessed against various STI biomarkers [36]; and
in one of the HPTN035 sites in Malawi CASI was compared with
face-to-face interviews [37]. CASI is becoming a popular method
through which to validate responses from face-to-face interviews,
but is also itself being validated against biomarkers. In an example
of the former, a CASI survey was conducted within the phase II
trial of Carraguard in South Africa to investigate whether
participants ever intentionally misled interviewers in face-to-face
interviews [38]; and among a subset of women who completed the
MIRA diaphragm trial, self-reported sexual behaviour via CASI
and face-to-face interviews was validated against a biomarker of
recent semen exposure [39].
Triangulation
Until we have validated biomarkers for all the behaviours that
are relevant to microbicide trials, such as adherence, sexual
behaviour, condom use – something that does not seem likely in
the near future – we will remain dependent on some form of self-
reporting for most of these data. And we will also continue to need
self-report data to inform us about the details of and reasons for
particular behaviours. It is therefore crucial to continue to develop
and improve methods so that the data we collect are as accurate as
they can possibly be. One way forward is to go beyond the parallel
use of different methods to triangulation.
The term triangulation is derived from surveying and
navigation, where it refers to finding a position – a fixed point –
by getting bearings on different objects. The methodological use of
the term is usually traced back to a 1959 article by Campbell and
Fiske [40]. Although there is no universally accepted definition of
research triangulation, it tends to refer to combining the results of
complementary methods in order to get more accurate result [20].
Campbell and Fiske refer to ‘‘convergent validation’’ [40].
This is a simplification, however, and in the literature on social
science research methods there has been heated discussion about
what triangulation is and is not, and whether it is possible at all
[41,42]. Basically, the controversy revolves around epistemological
issues: whether, in the social realm, there is a ‘‘fixed point’’ at all,
and whether the fact that method A agrees with method B makes
either method more valid. These issues are relevant for a number
of reasons. First, while we do not take a relativist position relating
to the ‘‘truth’’ of the behaviours we are studying, it is clear that this
truth is of a different order to the ‘‘fixed point’’ of the surveyors
and navigators, and most of the key behaviours that we try to
measure are ambiguous and difficult to define [43]. Second,
convergence does not necessarily mean truth: if we collect data on,
say, sex acts using different methods and the numbers are the
same, this does not necessarily mean that this is what ‘‘really’’
happened.
While a detailed consideration of these issues falls outside the
scope of this paper, we are raising them here because we want to
make clear that the triangulation model we describe here
represents an attempt to move beyond simply comparing methods
and trying to work out which is more accurate, toward developing
a more composite and holistic picture, while at the same time
accepting a necessary degree of uncertainty in the result. Perhaps
the term ‘‘triangulation’’ is not the ideal term for this process,
given its connotations of precision, but we will continue to use it
here for want of a better one. The model described below is based
on a model initially developed and used successfully for a number
of years to study sexual behaviour change in Uganda [44].
The Microbicides Development Programme
(MDP) Model
MDP301
MDP is an international partnership set up to evaluate vaginal
microbicides to prevent HIV transmission (www.mdp.mrc.ac.uk).
A major part of the programme has been MDP301, a multi-
centre, randomised, double-blind, placebo controlled trial that
aimed to determine the efficacy and safety of PRO-2000 gel in
preventing vaginally acquired HIV infection. The MDP301 trial
was carried out at three research centres in South Africa and one
each in Zambia, Uganda and Tanzania. The enrolment of 9,385
women was completed in August 2008 and follow up was
completed in August 2009. Participants were followed up for 12
months post-randomisation, except for Uganda where this was up
to 24 months. Participants were recruited from four main
populations: women from the general community with access to
primary health care facilities (South Africa and Zambia) or who
were entitled to primary care either through their employment or
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their partner’s employment (Zambia), women working in bars,
hotels, guesthouses and other food or recreational facilities
(Tanzania), and women in HIV serodiscordant relationships
(Uganda). To participate, women had to be 16 years or over in
Tanzania and Uganda, or 18 and over in the other countries,
sexually active, HIV negative and not pregnant [45]. The results
of the MDP301 trial were announced in late 2009, showing no
evidence that PRO-2000 provided protection against HIV
infection.
Feasibility and Pilot studies
Prior to the phase III trial, feasibility studies were conducted at
each of the centres to assess retention of participants during 12
months of follow up and to obtain estimates of HIV sero-incidence
rates, pregnancy, and condom use in settings where condoms were
promoted and provided free of charge and risk-reduction
counselling and STI treatment were provided. The feasibility
studies also assessed behavioural characteristics of the potential
study populations. A pilot study, using placebo gel, followed the
feasibility studies, and the results of this were used to inform the
final protocol for the phase III trial [45].
A substantial social science component was included from the
outset. The main objectives of this were to improve and assess the
accuracy of adherence and sexual behaviour data, collect detailed
data on sexual behaviour and vaginal hygiene practices, assess
participants’ comprehension of the study and the informed consent
procedures, and assess the acceptability of the product and trial
procedures [45].
At the start of the feasibility study it was not clear which
methods, apart from the conventional clinical CRFs, would be
used and what they would look like. Feasibility and pilot studies
facilitated internal discussion and consultation with the study
communities, as well as the development and testing of methods
and approaches.
Because concerns had been voiced about the feasibility and
acceptability of coital diaries in some of the study communities, the
social science teams at each of the centres developed different
formats and tested these in the study communities during the
feasibility study. Key questions were: should the diaries be pictorial
or text, how explicit should the pictures be and would this be
acceptable, which behaviours should they cover, how detailed
should they be. One site (Tanzania) tested five different formats
[46]. The result of this process was that the team agreed on a basic
generic format of a simple pictorial coital diary, and each site then
selected images that were locally comprehensible and acceptable.
One centre (Johannesburg) piloted CASI, in particular relating
to sensitive topics such as anal sex, but the results were not very
different from those achieved with interviews, and this, together
with technical difficulties at the time and the impracticality for
large study populations in some of the rural areas, led to the
decision not to use CASI. The use of mobile phones was also
considered and rejected for similar reasons.
Although the use and centrality of a case record form (CRF) for
the collection of behavioural data was assumed from the start, the
feasibility and pilot studies enabled it to be developed and tested in
parallel to the coital diaries and in-depth interview guides,
enabling the comparison of data for individual sex acts.
Another important aspect of the feasibility studies was to
investigate the local cultural context and clarify key concepts and
terms. This involved identifying key vernacular terms relating to
relationships and sexual practices and exploring their meanings.
Many of the relevant behavioural terms were highly ambiguous,
and this was further complicated by the multilingual nature of
some of the study sites. As a result there were often multiple
possible translations, none of which reflected the exact meaning of
the standard English terms that are used in this type of research.
The feasibility and pilot studies facilitated some refining of
translations and terminologies.
Mixed methods and triangulation in MDP301
The methods. Different methodological options were
assessed and developed during the feasibility study. An effort
was made to select methods that were relatively simple and feasible
across the different settings, and which had both complementary
strengths and different weaknesses (to reduce the possibility that
agreement in the results may be a result of sharing the same
weakness). These methods were then tested in the pilot study and
refined before being adopted in the trial:
N Structured interviews recorded on case record forms (CRF)
N Pictorial coital diaries (CD)
N Semi-structured in-depth interviews (IDI)
N Counting returned gel applicators
N Focus group discussions (FGD)
N Ethnography
This selection combines quantitative and qualitative, self-
assessment and face-to-face, and self-report and a more respon-
dent independent technique. The only potential biomarker
available at the time was the applicator stain test developed by
the Population Council [47,48], but this had not been validated
and it was decided that collecting and counting used and unused
gel applicators would provide a more respondent-independent
means of verifying self-reported adherence [49].
Focus group discussions with community members and trial
participants and ethnography carried out in the study communities
and clinics provided additional contextual information. The CRF,
CD and IDI were developed in parallel and covered the same
topics and the same time period in order to facilitate comparison.
The social science component. At each of the six African
centres a subset of women was randomly assigned to the social
science component of the study, which was responsible for the
triangulation. The target sample size for this subset was at least
100 per centre (i.e. a total of 600 women across the trial). This
number was thought to be small enough to enable the collection
of detailed qualitative data and yet large enough to generate
results that could be generalised to the whole trial population.
By the end of recruitment we had recruited a total of 725
women (7.7% of the trial population) into the social science
subsample.
All trial participants had 4-weekly clinic visits during which they
received gel and condom supplies, returned used and remaining
unused gel applicators, and were interviewed using a CRF. The
visits at weeks 4, 24, 40 and 52 were longer as they included a
clinical interview and examination and the CRF interview was
more detailed, containing questions about gel use, vaginal washing
and other practices, and detailed questions on each sex act during
the last week (or four weeks if the participant did not have sex in
the last week). The triangulation procedures were linked to three
of these long clinic visits, at weeks 4, 24 and 52. (It was felt that it
was sufficient to triangulate data early, in the middle and at the
end of follow-up and therefore unnecessary to also include these
procedures at week 40 as well).
The social science component of the trial was made up of teams
at each centre consisting of 4–5 interviewers led by a senior social
scientist. The social science component was coordinated centrally
to ensure standardised procedures and training.
Methods in Microbicides Trials
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The triangulation process (see Figure 1).
1. Coital diaries. Four weeks before the long clinic visits the
women randomised to the social science component received a
coital diary (CD) in which they recorded their sexual
behaviour, gel and condom use, and whether or not they
inserted anything other than study gel. During the clinic visit
they handed in their CD.
2. Applicator return. They also handed in their used and
unused gel applicators, and these were counted and recorded.
3. Clinic CRF interview. A member of the clinic staff then
interviewed them about sexual behaviour and gel use in the last
week (or 4 weeks if they had not had sex in the last week) using
a structured case record form.
4. Comparison form. Shortly after the clinic interview a
member of the social science team copied the key information
on sexual behaviour, gel and condom use from the CRF and
the CD onto a comparison form, which was integrated into the
in-depth interview guide. This enabled them to see any
inconsistencies at a glance.
5. In-depth interview. A few days later a social scientist
interviewed the participant, focusing on the same period as the
CD and the CRF interview and on the same behavioural and
product-related topics, but in a more open and informal
manner. Answers to the key questions on sexual behaviour and
gel adherence were also noted on the comparison form. During
this interview the interviewer also probed to find out the
reasons for any discrepancies between the data from different
methods, and attempted to establish the most accurate answer
in discussion with the participant. The final corrected result
was recorded on the comparison form. These interviews were
all recorded digitally.
6.Male partner interview. Consenting male partners of
participants who agreed were also interviewed about sexual
behaviour during the same period.
7. Summary database. The in-depth interview guide also
contained a summary section with pre-coded answers and
summary fields so that the interviewer could fill in the major
findings during or immediately after the interview. These
data, together with key data from the CD and the
comparison form, were entered into a summary database
that provided quick access to the results in a quantitative
format.
8.Quick feedback. Where relevant, the information from the
above process was fed back to the local clinic teams and to the
central Trial Management Group during monthly calls to
review progress [1].
9. Focus group discussions with trial participants and commu-
nity members about the gel, the trial, sexual behaviour and related
issues were carried out to collect more general information on
community attitudes. These were all recorded digitally.
Figure 1. Steps in the triangulation process.
doi:10.1371/journal.pone.0011600.g001
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10. Ethnography. Observations and informal conversations
were carried out in the study communities and clinics.
Sometimes these activities were aimed at specific problems
that arose during the trial.
11. Transcription and translation. The recorded in-depth
interviews, FGDs and notes from the informal conversations
and ethnography were transcribed, translated, and entered
in Nvivo, a software programme for the management and
analysis of qualitative data.
12. Coding and analysis. Transcriptions were all coded in
Nvivo and analysed to bring out more implicit meanings
and make comparisons between the study sites, using a
Grounded Theory approach [50,51]. Continuous analysis of
the data was carried out on a site level at the different
research centres as well as centrally across all sites.
13. Detailed final qualitative analysis.
The social science data. The final social science dataset
consists of 1866 in-depth interviews, most with matching CD,
CRF and applicator count data, from 725 women. In addition
there are 462 interviews with 244 male partners. There are also
100 FGDs with trial participants who were not randomised to the
social science component, 119 FGDs with community members,
and extensive ethnographic notes. These have all been transcribed
and coded in Nvivo.
Discussion
In this section we discuss some of the practical issues relating to
this approach, looking first at what worked and then considering
some of the problems and potential solutions.
What worked
Interdisciplinary collaboration. MDP301 demonstrated
that it is possible to integrate a substantial qualitative component
into a clinical trial, even one carried out under the stringent
criteria required for product licensing. It showed that this
approach can greatly enhance the quality and richness of key
trial data [1]. This success was partly based on the equality and
mutual respect between disciplines, equal representation in
management and coordination bodies, equity in the funding for
the different disciplines, and the commitment of the funder
(DFID/MRC) to this. This does not mean there were no tensions
or misunderstandings (see below), but they were easier to solve (or
to live with) given the democratic nature of the collaboration.
Feasibility and pilot studies. Although feasibility and pilot
studies are not essential for a mixed method approach, they did
enhance the quality of the collaboration and the data collection
tools. In addition to being important from a clinical trial
perspective for assessing HIV incidence and retention, the
feasibility studies provided space for the development of
innovative approaches to collecting sensitive information and the
opportunity to integrate these into a coherent methodological
whole. They were crucial for understanding the terminologies and
meanings that are necessary for developing valid instruments,
especially in multicultural and multilinguistic research settings.
They were also important for building trust between collaborators
from disciplines with very different approaches. Having a pilot
study between feasibility studies and trial was important for testing
trial and clinic procedures, gel distribution, etc., but also for
piloting the combination of methods and the triangulation
procedures.
The combination of methods. The combination of different
but complementary methodological approaches – quantitative and
qualitative, self-report and respondent independent, and self-
assessment and face-to-face – the development of new ways of
using and combining existing methods, and the use of
triangulation were some of the innovative aspects of this study
that worked well.
N Coital diaries (although not innovative as such) turned out
to be relatively easy and cheap to develop and deploy. Issues of
cultural sensitivity and local variations in how images are
interpreted were easily overcome by consulting communities in
the design. Differences between locations were overcome by
using a generic design with local variations in the images.
N Hybrid in-depth interviews/comparison forms proved
to be a powerful instrument for identifying inconsistencies
between data from different sources and for solving most of
these through discussion with participants and/or qualitative
interpretation of the data. A key aspect of this process was
asking participants to explain inconsistencies in their reporting.
Initially there had been some reluctance to include this, as it
was felt that participants would experience it as ‘‘threatening’’.
However, earlier experience [25] had shown that study
participants often welcome the opportunity to correct mistakes
and clarify misunderstandings. This was again clearly
demonstrated here, showing that it is possible to solve
inconsistencies during the study (rather than merely identifying
them after the study has been completed) thus increasing the
accuracy of the data [1]. The inclusion of tick boxes and
summary fields in the IDI guide meant that both qualitative
and quantitative data were being collected simultaneously.
N The summary database was a quick and efficient means of
generating quantitative data from the IDI and for comparing
data from different sources, and this enabled rapid feedback to
other sections of the trial. For example, information on
possible inaccuracies in the CRF interviews were fed back to
the clinic and enabled further interview training.
N Focus group discussions and ethnography in the clinic
and the community complemented the other methods by
providing data on the wider socio-cultural context and
generated information on problematic issues. For example,
FGDs shed light on gel sharing between participants, and
when gel use declined at one site informal conversations with
participants and analysis of the qualitative data showed that
this was due to a bottleneck in supply at the clinic rather than a
reduced acceptability. Somewhat unexpectedly, focus group
discussions also generated a lot of additional information on
topics that we had assumed would not be discussed because of
their sensitive nature, such as anal sex.
N Triangulation. As mentioned earlier, our aim was to move
beyond simply comparing different methods and attempting to
work out which is more accurate toward developing a more
composite and holistic picture (as well as a more accurate one)
based on data from a broad range of methods. There were
really two levels to this process: first, ‘‘simple’’ triangulation, in
which the results of different methods relating to sex acts, gel
use, etc. were discussed with participants and discrepancies
analysed and resolved; and second, broader, contextual
triangulation, in which the results from individual participants
were also related to more general data emerging from focus
group discussions and ethnography.
Some problems and possible solutions
Four main problem areas emerged from, or were highlighted
by, this approach.
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The nature of the topic and the cross-cultural context.
Although mitigated to some extent by the ethnographic work
during the preparatory phase, the sensitivity of the topics and
the lack of fit between the participants’ messy descriptions and
vague categories and the quantification and ostensibly precise
categories of the trialists meant that some ambiguity persisted in
the data (for example relating to what should be considered a
‘‘sex act’’). More ethnographic work could have been done to
clarify terminologies in the early stages. Here it is important to
focus on how researched communities use key concepts, rather
than simply asking what the words mean. The conventional
approach to questionnaire design, in which local translations of
questions are made and then back-translated may simply
reproduce standardised, though often inaccurate, matching
sets of terms. CRFs for such studies should be designed in a way
that more adequately takes intercultural ambiguities into
account.
Disciplinary assumptions and the clinical trial
context. Various tensions arose due to different disciplinary
assumptions and epistemologies. We give two examples. First,
quantitative medical researchers assume that in order for data to
be standardised and comparable, respondents must be asked
exactly the same question in exactly the same way. This requires
reading the question and related explanatory information
verbatim from the questionnaire. Here ‘‘the same question’’
refers to the wording and the delivery. From a qualitative
perspective, however, the focus is more on the respondents’
interpretation of the questions and what they mean by their
answers. In other words, it might be necessary to word and ask
questions differently in order to ask the ‘‘same’’ question and get
comparable answers. For example, it is clear from the in-depth
interviews that, as the trial progressed and participants became
familiar with the trial definition of a sex act, the meaning of the
questions about sex acts changed for them, while the wording of
the CRF questions (and their meaning for the trialists) remained
the same. This suggests that getting more reliable data might
actually require using more open questions.
Second, although it was accepted by the trialists that a degree of
flexibility was necessary in the collection of qualitative data, the
relatively inflexible clinical trial culture tended to impinge on this
freedom. For example, it was difficult to adjust the in-depth
interview question guide during the study because of the
assumption that it would then need new IRB approval. It also
took many months to get agreement (and then only in some
research centres) to carry out additional follow up interviews with
participants about suspected gel sharing and dumping, because
such interviews were not described in the trial protocol. This lack
of flexibility is partly due to the assumptions underlying
quantitative research and partly a result of the proliferation of
GCP rules and IRB requirements, which are perhaps appropriate
for clinical data collection but less so when applied to qualitative
behavioural studies.
Recruitment and training of interviewers. MDP invested
much time and effort in training interviewers, and it is difficult to
imagine that more could have been done. However, the
triangulation process revealed that many of the inaccuracies that
could be traced to the clinic CRF were a result of errors made by
the interviewers. This was confirmed when we recorded and
transcribed a sample of CRF interviews and compared these with
the completed CRFs for the same interviews. A similar problem
also bedevilled some of the in-depth interviews, which sometimes
left much to be desired with regard to the depth of the probing and
the follow-up of potentially interesting topics.
These problems might have been mitigated by more training,
and by better quality control (for example through regular
recording and comparison of a subsample of interviews, as
mentioned above, and the integration of this into a system of
ongoing training). But recruitment and selection of interviewers is
perhaps more crucial. It should not be simply assumed that with a
little interview training nurses and councillors make good
interviewers, or that because someone has a degree in social
science they are naturally able to do rich in-depth interviews.
Good interviewing techniques can be learnt, but some people have
more aptitude for this type of social interaction than others, and
this should be taken into account when recruiting interviewers (for
example by getting applicants to do an interview as part of the
selection process).
The size of the qualitative dataset and the duration of in-
depth interviews. This trial generated the largest set of
qualitative data that has ever been collected in a single study, as
far as we are aware. Although this had the advantage of enabling
us to generate numbers from qualitative data for a relatively large
and representative proportion of the trial population (7.7%) across
multiple sites, it also brought with it a number of technical
problems. For example, existing versions of software packages
designed to manage and code qualitative data proved incapable of
handling such a large dataset, and the data had to be spread across
numerous databases. Qualitative software developers need to work
toward increasing the capacity of the databases that are part of
their programmes.
Also, in-depth interviews are time consuming to do and,
especially, to transcribe, translate and code and, given the large
number of interviews, this frequently led to backlogs. However,
because only part of the in-depth interview was devoted to the
triangulation of adherence and sexual behaviour data, with the
rest focusing on other broader contextual issues, it should be
relatively easy to separate the triangulation process from the rest of
the in-depth interview, which could then be made into a much
shorter process involving all trial participants, limiting the rest of
the in-depth interview to a smaller sub-sample of participants. This
‘‘triangulation interview’’ could then be the source of the final
quantitative trial data on adherence and behaviour. These
triangulation interviews could be routinely recorded and a sub-
sample transcribed for training and quality control.
Conclusions
This paper has described the integration of qualitative and
anthropological methods and innovative quantitative methods into
a large multi-centre clinical trial, and the triangulation of results in
order to obtain more accurate data on product use and sexual
behaviour. While there are various examples of the use of mixed
methods in clinical trials, the Microbicides Development Pro-
gramme has, as far as we are aware, developed and implemented
the most comprehensive combination of mixed methods and
triangulation in a clinical trial to date. The study is unique in
having integrated these into the trial in order to improve accuracy
rather than using them for parallel or retrospective evaluations,
and in the way that the qualitative data were collected from a
substantial representative sample of the trial population. The key
innovative aspect is the identification and resolution of inaccura-
cies in the data during the study in a process that involved a
customised in-depth interview and dialogue between researchers
and participants.
It is often argued that this type of research is time consuming,
that it costs too much, and that the results are not ‘‘objective’’. But
if it is not done then trialists risk having spent millions of dollars
and still ending up not knowing what it was they paid so much to
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find out. The experience in MDP301 suggests ways of re-thinking
how we get a true grip on the most challenging aspect of HIV
prevention research: adherence to protocol and to prevention
behaviours that require enduring commitment.
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